Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Clinical Trial Support Services Market

  • MAR2979030
  • 194 Pages
  • April 2018
  • Pharmaceuticals
Download Sample    Get Discount   
 
Introduction

Clinical Trials researches involve researches done on people. It tests whether a particular procedure or a drug is safe and how well it works. They are designed to improve health and quality of life. Clinical Trial Support Services is a resource that standardize clinical and administrative procedures to conduct human research. It does so ensuring that the research withstands any legal scrutiny and follows the clinical practice guidelines. The following services are provided by Clinical Trial Support Services to the Clinical Investigators: Patient Recruitment, Clinical Research education and training, Clinical trial data management, Clinical research nurse and clinical research coordinator services, Financial services, including invoicing of research sponsors, processing of sponsor payments and payment of study-related expenses, Regulatory submissions to regulatory Health body in the country, including Clinical Trial Applications, Review and negotiation of confidential disclosure agreements, Negotiation of contracts and study budgets, Preparing and submitting ethics applications, Preparing and submitting applications for health region approval, Preparation and processing of regulatory documents, blinding of study drug, and more.

Market Dynamics

The array of new diseases that we are recognizing every day, and our quest to find the cure for the same are driving the need for newer drug development which in turn is driving the need for clinical trials hence the need for clinical trial support services is on a rise. But increasing amount of investment during the entire process of the trial i.e. right from the patient recruitment to the analysis proves to be hindrance in its growth.

Market Segmentation

The Market has been segmented on the basis of Clinical Trial Cycle which includes: Pre-Clinical, Phase I, Phase II, Phase III. The Pre-Clinical includes: Biomarker Discovery/Development, Assay Design and Development for Research Assay, Clinical Trial Strategy Design to Include Diagnostic. Phase I includes Early-Phase Patient Screening, Sample Collection Management, Data Management Assay Redesign, if Necessary, Pre-Sub Meeting (IND/IDE), Assay CLIA Validation for Clinical Trial Assay. Phase II includes Regulatory Support for IDE Process, Target Patient Population Identification, Sample Collection Management, Data Management, Clinical Trial Testing Services Under CLIA Guidelines, CMO Identification for Research Use Only Kit. Phase III comprises of PMA, NDA Submission , Drug Approval, Global Diagnostic Manufacturing and Commercialization Strategy.

Regional/Geographic Analysis

The United States and Canada in North America; China, Japan, India in Asia-Pacific; Germany, UK, France, Italy and Russia in Europe; Brazil in South America have the largest market in their respective regions.

Key Players

Some of the major players in the market include Alcura Health, Quintiles, Parexel, Pharmaceutical Product Development, LLC, Covance, ICON Plc.

Report Contents:

> Market segments

> Market Drivers, Restraints and Opportunities

> Market Size & Forecast 2016 to 2022

> Supply & Demand Value Chain

> Market - Current Trends

> Competition & Major Companies

> Technology and R&D Status

> Porters Five Force Analysis

> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)

>> Nordic Countries (Denmark, Finland, Norway, and Sweden)

>> Benelux (Belgium, The Netherlands, and Luxembourg)

>> Rest of Western Europe

> Eastern Europe

>> Russia

>> Poland

>> Rest of Eastern Europe

> Asia Pacific

>> China

>> India

>> Japan

>> Australia and New Zealand

>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)

>> South Africa

>> North Africa

>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)

> Consumer and Pricing Analysis

> Market dynamics of the industry

> Market Segmentation

> Estimated Market Sizing in terms of volume and value

> Recent trends in Market and impact

> Research Status and Technology Overview

> Extensive Industry Structure Coverage

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390